Skip to content

Clinical trials

Observational Muscular Atrophy, Spinal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy, Spinal Phase: Observational Clear all

112 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20061
20083
20092
20101
20111
20123
20134
20142
20155
20165
20175
201810
20198
20205
20219
202213
20237
20248
20256
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Recruiting26
Unknown status22
Active, not recruiting9
Not yet recruiting5
Withdrawn3
Enrolling by invitation2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS8
Columbia University7
Novartis Pharmaceuticals7
Biogen5
National Taiwan University Hospital4
University of Miami4
Hospices Civils de Lyon3
National Institute of Neurological Disorders and Stroke (NINDS)3
Nemours Children's Clinic3
Ohio State University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy, Spinal112
Amyotrophic Lateral Sclerosis18
Neuromuscular Diseases16
Motor Neuron Disease15
Spinal Muscular Atrophies of Childhood12
Muscular Dystrophy, Duchenne7
Frontotemporal Dementia4
Muscular Dystrophies4
Disease Progression3
Spastic Paraplegia, Hereditary3

Trials

Showing 1 to 25 of 112. Each trial links to its page on Pharma Observatory.

12 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.